Singapore, Feb 3, 2023 – (ACN Newswire) – ION Mobility (ION) today announced new investments of US$18.7 million in its Series A funding round. Additionally, the company also brings TVS Motor Company on board as its strategic investor, through TVS Motor’s Singapore subsidiary, TVS Motor (Singapore). As part of this investment agreement, TVS Motor will provide ION with the necessary ecosystem support to be successful in the electric two-wheeler markets of Singapore and Indonesia.

ION’s latest fundraise and partnership with TVS Motor is to support its vision to build Southeast Asia’s leading electric mobility solutions company starting with Indonesia. Other investors include AC Ventures Malaysia, Michael Sampoerna and ION’s Chief Manufacturing Officer Ng Ho Sen, with existing investors such as TNB Aura, Quest Ventures, Monk’s Hill Ventures, Village Global, GDP Venture and Seeds Capital also participating in the round.

Founder and CEO James Chan said, “I am delighted with the vote of confidence that my team and I have received from TVS Motor via our funding round and partnership. We are excited to draw upon TVS Motor’s decades of global expertise in two-wheelers to accelerate our “Mobius” M1-S production readiness, as well as the design and development of other models. We look forward to leading the charge towards an electric and sustainable two-wheeler future together.”

This new funding round brings the total capital raised by ION to over US$25.5 million since 2020. The company will invest the capital into Indonesia to grow its local team, operations and capabilities. This includes its sales and marketing presence, local supply chain networks, production tooling and manufacturing capabilities in Indonesia, in order to achieve at least 50% local content.

Speaking on the occasion, Mr. Sudarshan Venu, Manging Director, TVS Motor Company said, “TVS Motor is committed to developing exciting products for consumers across global markets. We are thrilled to partner with ION Mobility, a full-stack EV company with a strong team of engineers and technical base in Singapore, to drive the premium electric two-wheeler growth in the region. We share a common vision and are eager to support them as a strategic investor.”

This announcement comes on the heels of ION Mobility’s launch of its M1-S electric scooter in Jakarta in November 2022, which also saw the company sign a broad-ranging Memorandum of Understanding (MOU) with Indonesia’s national grid operator PT Perusahaan Listrik Negara (PLN) to expand PLN’s charging network, in addition to two-wheeler fast-charging technology research and user outreach and education. The MoU was officiated by Indonesian Minister of Industry, Agus Gumiwang Kartasasmita at the Indonesia Motorcycle Show 2022, with Singapore Ambassador to Indonesia Mr. Kwok Fook Seng also in attendance.

About ION Mobility

ION Mobility is a tech and automotive OEM on a mission to create and deliver aspirational and sustainable mobility and energy solutions for everyone. They are committed to creating great products and seamless user experiences for their customers. Their products combine advanced hardware and software technology with human-centred design to deliver smart electric motorbikes and energy charging and storage solutions that are for everyone to use. Their vision is to be Southeast Asia’s top technology company leading their region’s transition towards a low-carbon economy across Southeast Asia, starting with the ION M1-S. For more information, please visit http://www.ionmobility.com and ionmobility.substack.com.

For more information, please contact: hello@ionmobility.com

About TVS Motor Company

TVS Motor Company is a reputed two and three-wheeler manufacturer globally, championing progress through Sustainable Mobility with four state-of-the-art manufacturing facilities in Hosur, Mysuru and Nalagarh in India and Karawang in Indonesia. Rooted in their 100-year legacy of Trust, Value, and Passion for Customers and Exactness, they take pride in making internationally aspirational products of the highest quality through innovative and sustainable processes. They are the only two-wheeler company to have received the prestigious Deming Prize. Their products lead in their respective categories in the J.D. Power IQS and APEAL surveys. They have been ranked No. 1 Company in the J.D. Power Customer Service Satisfaction Survey for consecutive four years. Their group company Norton Motorcycles, based in the United Kingdom, is one of the most emotive motorcycle brands in the world. Their subsidiaries in the personal e-mobility space, Swiss E-Mobility Group (SEMG) and EGO Movement have a leading position in the e-bike market in Switzerland. TVS Motor Company endeavours to deliver the most superior customer experience across 80 countries in which they operate. For more information, please visit http://www.tvsmotor.com.

For more information, please contact:

KS Harini – ks.harini@tvsmotor.com

Nikita Verma – nikita.verma@tvsmotor.com

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

New York, NY, Dec 27, 2022 – (ACN Newswire) – That cuddly bear and his motley pals are headed for the big screen, thanks to Baboon Animation and IQI Media, Inc., in a prequel to the A.A Milne’s classic book ‘Winnie -the-Pooh’.

“We’re tell the surprising origin story of the ‘silly young bear’ and his friends, when they were still kids, in a way designed to connect with 21^st-century kids,” say Reynolds.

DreamWorks alumnus Mike de Seve (Madagascar, Monsters vs. Aliens) will direct, and co-write with fellow DreamWorks alum John Reynolds (The Mr. Peabody & Sherman Show).

Multi-Emmy-winning animation writing stars Baboon (Angry Birds, Gigantosaurus) have teamed up with IQI, a content incubator lab and subsidiary of WINVEST GROUP (OTCMKT:WNLV), to produce the prequel feature. DreamWorks alum Charlene Kelly (Next Gen), now CIO at Winvest, and Khiow Hui Lim, the founder of IQI and CSO of Winvest, will executive-produce.

“A.A. Milne’s bear has aged gracefully in the last hundred years,” said Kelly. “But what happened, back-when, that made him and his pals who they are in the book? A heck of a big adventure, that’s what – one that needs a big screen. Audiences will be transported to somewhere they never expected.”

“I think this unsinkable young cub is totally relatable for today’s kids, with his hell-bent craving for honey and his ludicrous schemes to get it,” adds de Seve, who directed on the original Beavis and Butt-Head series and feature and story-consulted on Shrek 2. He now helms Baboon, :The whole gang is hilarious, and are even more hilarious as kids, we’re finding out.”

Noting the success of the reboots of Peter Rabbit and Paddington, the Baboon team is applying its knowledge of entertainment for today’s kids to create characters they hope will resonate with all generations.

Baboon and IQI have set a planned release date of 2024 for the feature, followed immediately by the series. What will the young bear and his friends look like? ” You’ll see,” laughed Kelly. “Brace yourself for a surprise.”

With 31 Emmys Collectively, Baboon Animation’s team members provide world-class showrunning, writing, development and voices on some of the most successful brands globally. Mediare inquiries: news@baboonanimation.com .

Charlene Kelly, Executive Producer at IQI Media and CIO at Winvest, and Khiow Hui Lim, the founder of IQI and CSO of Winvest, will executive-produce the project. Interested financial partners can contact them at charlene_k@iqimedia.com and khiowhui@iqimedia.com

Media Contact
Agnes Tham, Investor Relations, Winvest Group Ltd.
Telephone: +1 (775) 996-0288
Email: info@winvestgroup.co
Website: https://www.winvestgroup.co/

SOURCE: Winvest Group Ltd.

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Singapore, Dec 21, 2022 – (ACN Newswire) – DOKODEMO is expanding its international marketing and business with a new office in Singapore. Singapore is one of the top-ranked financial hubs globally, with huge potential to maintain the company position.

The branch office- which is located at Suntec Tower in Singapre town centre – brings its professional face-to-face assistance and providing an user-centric office fit for the leading global organisation. The company will be more stable with its presence in Asia Pacific and continuing on its international expansion journey.

DOKODEMO has strong Ecommerce and marketing experience and their customer service team knows what it takes to deliver a straightforward service. With DOKODEMO DATA MARKETING PTE. LTD. , based in Singapore, the company is able to provide more opportunities and support for users to discuss about their concerns in person. This is a personal approach that builds trust with the partners and users.

According to DOKODEMO Singapore Country Manager Albert Martin, “We always believes that the philosophy of staying close to the clients will allow us to serve the clients faster and more effectively. It’s our highly personalised approach that makes us most proud and is why we are expanding. Teamwork and customer service are both important. Everyone should have the chance to build a creditworthy future.” he said.

This extensive branch network also means that many of DOKODEMO’ users especially from Asia can meet and exchange their ideas and information easily. The new office could also allow the company to maintain a good reputation and cooperate with the leading merchants in Singapore for the business growth. This is one of the essential step for DOKODEMO to go public by making the company and services known to a wider potential swath of customer base.

Media Contact
Albert Martin, DOKODEMO DATA MARKETING PTE. LTD.
Email: support@dokodemo.global
Website: https://www.bandaomall.com
City: Singapore
Address: Suntec Tower Three, 8 Temasek Blvd, 038988(SG)

SOURCE：DOKODEMO DATA MARKETING PTE. LTD.

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

SHENZHEN, CHINA, Dec 20, 2022 – (ACN Newswire) – Gelonghui released a Press Release on “China Medical System Holdings Limited’s innovative product Methylthioninium Chloride Enteric-coated Sustained-release Tablets (‘the Product’) has obtained positive results for its Phase III clinical trial in China.”

This is another breakthrough for the Product after China Medical System Holdings Limited (“CMS” or the “Group”) had efficiently completed the enrollment of all 1,802 subjects for its China Phase III Clinical Trial in July this year, of which only 6 months (including the Spring Festival Holiday) was taken. The Group will actively move forward the Product’s new drug application (NDA) in China.

In this China Phase III clinical trial, Methylthioninium Chloride Enteric-coated Sustained-release Tablets was compared to placebo with the purpose of assessing its safety and efficacy in the improvement of histologically confirmed non-polypoid colorectal lesions in subjects undergoing screening or surveillance colonoscopy for colorectal cancer. The research was led by Beijing Friendship Hospital, Capital Medical University and conducted in 22 sites nationwide. In total, 1802 subjects were randomized, 897 in the Product arm and 905 in the placebo arm. Of those, 872 in the product arm and 879 in the placebo arm were in the primary efficacy population (FAS: Full Analysis Set).

The study met the primary endpoint with very high statistical significance:

in the overall FAS, the proportion of patients with at least one histologically confirmed non-polypoid colorectal lesion was significantly higher in the Product group (445/872 subjects; 51.0%) as compared with placebo (362/879, 41.2%); (adjusted OR [95% CI]: 1.55 [1.27, 1.89]; P< 0.0001).

The study also confirmed the superiority of the Product versus placebo in several clinically meaningful endpoints:

a) Number of histologically confirmed non-polypoid colorectal lesions per patient

In the FAS, the per patient number of histologically confirmed non-polypoid colorectal lesions in the Product group was 0.9, as compared to 0.7 in the placebo group (difference between groups [95%CI]: 0.18 [0.07，0.30] P=0.0022).

b) Number of histologically confirmed non-polypoid adenomas or cancers per patient

In the FAS, the per patient number of histologically confirmed non-polypoid adenomas or cancers in the Product group was 0.6 as compared to 0.5 in the placebo group (difference between groups [95%CI]: 0.12 ([0.03，0.22] P=0.0125).

c) Detection rate of non-polypoid adenoma or cancer (NP-ADR)

In the FAS, 341 out of 872 patients (39.1%) were detected with at least one histologically confirmed non-polypoid adenoma in the Product arm. as compared with 274 out of 879 patients in the placebo group (31.2%) (OR [95%CI]: 1.43 [1.17，1.75] P=0.0004).

d) Proportion of patients with at least one histologically confirmed <10 mm non-polypoid colorectal lesion

Non-polypoid histologically confirmed colorectal lesions less than <10 mm were found in 415 out of 872 patients (47.6%) in the Product group versus 350 out of 879 patients (39.8%) in the placebo group (OR [95%CI] 1.43 [1.17，1.74] P= 0.0003).

e) Number of histologically confirmed <10 mm non-polypoid colorectal lesions per patient

In the FAS, the per patient number of histologically confirmed non-polypoid colorectal lesions < 10 mm was 0.9 in the Product group versus 0.7 in the placebo group (difference between groups [95%CI]: 0.15 [0.03，0.26] P=0.0110).

f) Number of histologically confirmed non-polypoid adenomas or cancers <10 mm per patient

Overall, the per patient number of histologically confirmed non-polypoid adenomas or cancers <10 mm was 0.6 in the Product test group versus 0.5 in the placebo group (difference between groups [95 %CI]: 0.11 [0.02，0.20] P=0.0199).

No serious adverse events related to the drug were reported in this clinical study, and the product is well-tolerated with good safety.

Alessandro Della Chà, CEO of Cosmo Pharma, said: “We are very thankful to our partner CMS for this great clinical outcome, which is in line with our expectations and further confirms the data coming from our prior trial. The Product has proven once again its capacity of helping in particular the detection of the <10mm flat lesions, which are the most dangerous. We are thus very much looking forward to bring the Product in the Chinese market, which is the largest colonoscopy market of all“.

In an interview with Gelonghui, Mr. Yin, Director of Medical Department of CMS, said: “These excellent results showed that Product could enhance visualization of the colorectal lesions in subjects undergoing screening or surveillance colonoscopy, thus to help improve the detection rate of non-polypoid lesions, in order to reduce the mortality of colorectal cancer indirectly. We expect the Product will be marketed in the China soon, to potentially benefit tens of millions of people who get colonoscopies in China.“

About Methylthioninium Chloride Enteric-coated Sustained-release Tablets

Methylthioninium Chloride Enteric-coated Sustained-release Tablets is a novel oral formulation of the existing liquid colon staining dye methylene blues. Formulated by the proprietary MMX sustained-release technology of the Group’s partner Cosmo, it delivers the dye in a delayed and controlled way, distributing evenly through the full length of the colon, which enhances visualization of the colorectal lesions in subjects undergoing screening or surveillance colonoscopy, thus to help improve the detection rate of colorectal cancer/precancerous lesions.

About Gelonghui

Founded in 2014, Gelonghui is a leading global investment research platform in China. For the first time in China, it put forward the investment concept of “global vision, betting on China”, integrating financial media, research, investment banks, databases and other roles.

Media Contact
Address: Dachong International Center, Yuehai Street, Nanshan District, Shenzhen
Business Team, Gelonghui
Email: business@gelonghui.com
Tel: +86（0755）86533750
Website: https://www.gelonghui.com/

SOURCE: Gelonghui

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

SHENZHEN, CHINA, Dec 19, 2022 – (ACN Newswire) – Gelonghui released a Press Release on "China Medical System Holdings Limited's innovative product Methylthioninium Chloride Enteric-coated Sustained-release Tablets ('the Product') has obtained positive results for its Phase III clinical trial in China."

This is another breakthrough for the Product after China Medical System Holdings Limited ("CMS" or the "Group") had efficiently completed the enrollment of all 1,802 subjects for its China Phase III Clinical Trial in July this year, of which only 6 months (including the Spring Festival Holiday) was taken. The Group will actively move forward the Product's new drug application (NDA) in China.

In this China Phase III clinical trial, Methylthioninium Chloride Enteric-coated Sustained-release Tablets was compared to placebo with the purpose of assessing its safety and efficacy in the improvement of histologically confirmed non-polypoid colorectal lesions in subjects undergoing screening or surveillance colonoscopy for colorectal cancer. The research was led by Beijing Friendship Hospital, Capital Medical University and conducted in 22 sites nationwide. In total, 1802 subjects were randomized, 897 in the Product arm and 905 in the placebo arm. Of those, 872 in the product arm and 879 in the placebo arm were in the primary efficacy population (FAS: Full Analysis Set).

The study met the primary endpoint with very high statistical significance:

In the overall FAS, the proportion of patients with at least one histologically confirmed non-polypoid colorectal lesion was significantly higher in the Product group (445/872 subjects; 51.0%) as compared with placebo (362/879, 41.2%); (adjusted OR [95% CI]: 1.55 [1.27, 1.89]; P< 0.0001).

The study also confirmed the superiority of the Product versus placebo in several clinically meaningful endpoints:

a) Number of histologically confirmed non-polypoid colorectal lesions per patient
In the FAS, the per patient number of histologically confirmed non-polypoid colorectal lesions in the Product group was 0.9, as compared to 0.7 in the placebo group (difference between groups [95%CI]: 0.18 [0.07, 0.30] P=0.0022).

b) Number of histologically confirmed non-polypoid adenomas or cancers per patient
In the FAS, the per patient number of histologically confirmed non-polypoid adenomas or cancers in the Product group was 0.6 as compared to 0.5 in the placebo group (difference between groups [95%CI]: 0.12 ([0.03, 0.22] P=0.0125).

c) Detection rate of non-polypoid adenoma or cancer (NP-ADR)
In the FAS, 341 out of 872 patients (39.1%) were detected with at least one histologically confirmed non-polypoid adenoma in the Product arm. as compared with 274 out of 879 patients in the placebo group (31.2%) (OR [95%CI]: 1.43 [1.17, 1.75] P=0.0004).

d) Proportion of patients with at least one histologically confirmed <10 mm non-polypoid colorectal lesion
Non-polypoid histologically confirmed colorectal lesions less than <10 mm were found in 415 out of 872 patients (47.6%) in the Product group versus 350 out of 879 patients (39.8%) in the placebo group (OR [95%CI] 1.43 [1.17, 1.74] P= 0.0003).

e) Number of histologically confirmed <10 mm non-polypoid colorectal lesions per patient
In the FAS, the per patient number of histologically confirmed non-polypoid colorectal lesions < 10 mm was 0.9 in the Product group versus 0.7 in the placebo group (difference between groups [95%CI]: 0.15 [0.03, 0.26] P=0.0110).

f) Number of histologically confirmed non-polypoid adenomas or cancers <10 mm per patient
Overall, the per patient number of histologically confirmed non-polypoid adenomas or cancers <10 mm was 0.6 in the Product test group versus 0.5 in the placebo group (difference between groups 95 %CI]: 0.11 [0.02, 0.20] P=0.0199).

No serious adverse events related to the drug were reported in this clinical study, and the product is well-tolerated with good safety.

Alessandro Della Cha, CEO of Cosmo Pharma, said: "We are very thankful to our partner CMS for this great clinical outcome, which is in line with our expectations and further confirms the data coming from our prior trial. The Product has proven once again its capacity of helping in particular the detection of the <10mm flat lesions, which are the most dangerous. We are thus very much looking forward to bring the Product in the Chinese market, which is the largest colonoscopy market of all".

In an interview with Gelonghui, Mr. Yin, Director of Medical Department of CMS, said: "These excellent results showed that Product could enhance visualization of the colorectal lesions in subjects undergoing screening or surveillance colonoscopy, thus to help improve the detection rate of non-polypoid lesions, in order to reduce the mortality of colorectal cancer indirectly. We expect the Product will be marketed in the China soon, to potentially benefit tens of millions of people who get colonoscopies in China."

About Methylthioninium Chloride Enteric-coated Sustained-release Tablets

Methylthioninium Chloride Enteric-coated Sustained-release Tablets is a novel oral formulation of the existing liquid colon staining dye methylene blues. Formulated by the proprietary MMX sustained-release technology of the Group's partner Cosmo, it delivers the dye in a delayed and controlled way, distributing evenly through the full length of the colon, which enhances visualization of the colorectal lesions in subjects undergoing screening or surveillance colonoscopy, thus to help improve the detection rate of colorectal cancer/precancerous lesions.

About Gelonghui

Founded in 2014, Gelonghui is a leading global investment research platform in China. For the first time in China, it put forward the investment concept of "global vision, betting on China", integrating financial media, research, investment banks, databases and other roles.

Media Contact
Address: Dachong International Center, Yuehai Street, Nanshan District, Shenzhen
Business Team, Gelonghui
Email: business@gelonghui.com
Tele: +86 (0755) 86533750
Website: https://www.gelonghui.com/

SOURCE: Gelonghui

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

NEW YORK, NY, Dec 7, 2022 – (ACN Newswire) – Nonfinite is proud to announce that Nonfinite will be using Binance as one of their liquidity partner for the BTC/USDT spot trading via Binance, Kucoin, and Bitfinex Instituional. Nonfinite will allow their users to deposit and withdraw to their Binance, Kucoin, and Bitfinex wallet address instantly without fees.

Oh Shen King, CEO of Nonfinite labels this as the swap transaction optimization. Nonfinite users can save gas fees. At the same time, they are able save the energy consumption on blockchain mining. Currently the declared blockchain mining consumption is taking up as much 150 terawatt-hours of electricity annually.

Nonfinite runs crypto business for years, but they care about solutions to minimize carbon neutrality footprint. Nonfinite also provide their users with a new feature, they call it as Checker.

Nonfinite CEO says, “Checker allows our users to identify or check their incoming transaction address sources are reputable or flagged addresses. Sometimes, an address could be link to multiple transaction which involve illegal issues or money laundry. Checker can provide a good solution for a more secure trading environment.”

Nonfinite CEO adds, “We don’t want our big whales, wallet address link to all those activity, we doing our best to serve our whales and traders. With this feature Nonfinite user able to verify the sender address first before accept the crypto from the sender, as well as their receiver address is in good standing before sending them crypto. We will do our best to serve big whales and traders. With Checker’s solution, all users are able to verify the sender’s address before accepting crypto payment. Also they can make it clear if the recipient address in good condition before sending the crypto to them.”

Nonfinite is also currently in progress to join Blockchain.info Kucoin, and Coinbase’s institutional partner program.

Social Links
Instagram: https://www.instagram.com/nonfinite.ex

Media Contact
Media team, Nonfinite
Email: admin@nonfinite.com
Website: https://nonfinite.com

SOURCE: Nonfinite

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

SHENZHEN, CHINA, Dec 6, 2022 – (ACN Newswire) – A series of “Overseas Talents’ China Visit to Shenzhen” events were successfully held in Guangming district, Shenzhen from November 21 to 22. The events were co-organized by Shenzhen Center for International Exchange of Personnel.

The events are hosted by the China Association for International Exchange of Personnel, the Shenzhen Science and Technology Innovation Commission, the Communist Party of China Guangming District Committee, and the Shenzhen Guangming District People’s Government.

Presented by Guangming District Talent Work Bureau and Guangming District High-level Talent Service Center and co-organized by Shenzhen International Personnel Exchange Center, the series of events feature visits and exchanges by foreign experts, a forum for global experts and an exchange activity for Chinese and foreign guests named “The Night of Guangming”, to name a few.

The foreign experts symposium under “Overseas Talents’ China Visit to Shenzhen” was held via video link in Beijing and Shenzhen on the afternoon of November 21.

Li Xin, Deputy Director-General of the Department of Foreign Expert Services of China’s Ministry of Science and Technology, Xia Bing, Deputy Director of China Association for International Exchange of Personnel, Cheng Buyi, Member of the Standing Committee of the CPC Shenzhen Municipal Committee and Minister of the Organization Department, Cai Ying, Secretary of the Guangming District Party Committee, attended the meeting and delivered speeches through online and offline channels. Qiu Haohang, Deputy Secretary of the Guangming District Party Committee and Chief of Guangming District, presided over the meeting.

The events gathered academicians and experts from six countries, including the US, the UK, Italy, Germany, France and Cuba, putting the spotlight on topics such as original innovation breakthroughs, scientific research and economic development, talents opening up, and talent highland construction.

Answering the requirements of “facing the world’s scientific and technological frontier, facing the main economic battlefield, facing major national strategic needs and facing people’s life and health”, the series of activities gave Shenzhen a thorough examination and offered suggestions based on the city’s industrial development characteristics and its environment for innovation and entrepreneurship.

Aimed at tapping into the innovation plateau with talents, the events help the Guangming district to speed up the construction of a world-class science city and to become a representative and pioneer for Shenzhen’s participation in future technology competitions.

During the events, foreign experts also visited Shenzhen Engineering Biological Industry Innovation Center, Feiyada Museum, Shenzhen Bay Laboratory, Dadingling Greenway — Hongqiao Park and other research institutes and key enterprises. They listened to the introduction of institutions, and exchanged with scientific and technological personnel, laying the foundation for future cooperation.

Media contact
Wang Chan, Shenzhen Center for International Exchange of Personnel
Email: wangchan@ciep.gov.cn
Tel: 0755-81707961; 0755-81773121
Website: http://www.ciep.gov.cn/

SOURCE: Shenzhen Center for International Exchange of Personnel

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Hanzhou, China, Dec 4, 2022 – (ACN Newswire) – Jiande Municipal Committee announces that the on-site meeting of ‘Beautiful Countryside Construction – Qianwan Project’ is held in Jiande city, Hangzhou city. The on-site meeting was held on December 2nd. The delegates from Hangzhou walked into the countryside with great interest and experienced the charm of Jiande beautiful countryside.

Since Zhejiang implemented the project of “Demonstration of Thousand Villages and Renovation of Ten Thousand Villages” in 2003, Hangzhou has adhered to the idea of “lucid waters and lush mountains are invaluable assets” as its development, and continuously promoted the “Qianwan Project”. Hangzhou is also leading in beautiful countryside construction. It is understood that 85% of the existing more than 2,000 villages in Hangzhou have built beautiful countryside. By the end of this year, Hangzhou will have built a “beautiful countryside” in an all-round way. This on-site meeting will plan the objectives, tasks, carriers and practical paths for Hangzhou to further promote the “Qianwan Project”, build a livable, suitable industry and beautiful countryside, and work together to write a new chapter of high-quality development.

In recent years, centering on the general goal of “promoting common prosperity and building a livable Jiande in an all-round way”, in the construction of beautiful countryside, it has adhered to the principle of party building to guide convergence, optimize ecology, promote industrial development, resolutely adhered to the ecology, pushed forward the “Qianwan Project” in depth, and drew a blueprint for common prosperity. It has successively won the title of “Encouraging County” with obvious improvement effect on rural human settlements in the State Council, Beautiful Countryside Model County in the new era.

On the same day, Fu Yongwei, secretary of Jiande Municipal Committee, talked about “protecting the ecology and creating a beautiful home for common prosperity” at the meeting. Jiande’s “Three Persistences” got a good response at the meeting. Taking “environment” as the foundation, it continuously polishes the beautiful rural ecological outlook; Taking “industry” as the core, it continuously promotes the beautiful countryside economic value; With “people’s livelihood” as the core, the happiness of beautiful countryside is constantly improved. In the next step, Jiande will continue to promote the construction of beautiful countryside, make efforts to strengthen the village and enrich the people, and make greater contributions to the vivid practice of “two pioneers” in rural Hangzhou.

Beautiful countryside not only makes villages beautiful, but also drives industries. Zhijiang Village is one of the first batch of 36 “future villages” in China, and the delegates praised its “beauty has turned into a bright future”. On both sides of Xin’an River in Zhijiang Village, ten photography spots were designed along the way, such as “Fishing Boat Singing in the Evening” and “Boating Amid the Smoke”, which attracted many photographers and beautiful women and brought great popularity to local homestays. During this period, the delegates also went deep into the school, market and other places to experience the effectiveness of beautiful countryside’s construction.

Zhejiang’s strawberry is in Jiande, and Jiande’s strawberry is in Yangcun Bridge. At Yangcun Bridge, the delegates visited the strawberry planting history, the construction mode of agricultural industry “standard field” and the talent project of “strawberry master” in Jiande through greenhouse, strawberry co-prosperity workshop and aerial strawberry science and technology planting demonstration garden, and got a deep understanding of outstanding rural talents such as “Qiangcun Company”, “co-prosperity workshop”, “Nongchuangke” and “Jiande Master”, which made important contributions to the rise of beautiful countryside.

In Meicheng Town, the delegates visited the provincial-level Intangible Cultural Heritage program of Yanzhou Shrimp Lantern in “Qianhe Family” Square, and visited Qianhe Culture Auditorium, Heju Living Room, Qianhe Women’s Militia Heritage Hall, Hejia Children’s Hall and other places, and experienced the historical and cultural charm of the revival of this thousand-year-old city, and felt the new look of beautiful countryside construction in the new era.

How to build the beautiful countryside in the new period? In the afternoon, the meeting shows the video of “Beautiful Village, a Prosperous Future”. Hangzhou Agriculture and Rural Bureau (Hangzhou), Jiande city, Linping District, Zhongshan Township, Fuyang District, Lishan Town and Anding Village respectively exchanged their experiences.

The goal of the “Five Beauties” construction is: to build beautiful countryside in the new era, there must be the harmony between landscape and nature, the blending of modern and traditional humanities, the beauty of vitality in which livable and suitable for business complement each other, the beauty of coordination between urban and rural development, and the beauty of harmony between civilization and good governance.

To this end, Hangzhou has issued the “Seven Actions”, and put forward specific requirements from rural construction, human settlements improvement, industrial revitalization, public service improvement, modernization of governance, strengthening villages and enriching people, and digital rural construction. For example, Hangzhou will start a number of digital villages and future rural construction next year, and further improve the overall mechanism of reserved land in villages and towns to promote the flow of urban resources to villages.

“Hangzhou should solidly promote the revitalization of rural industries, talents, culture, ecology, organization and other aspects, and strive for the common prosperity and modernization of Hangzhou.” The relevant person in charge of Hangzhou Agriculture Bureau (Hangzhou Rural Revitalization Bureau) said.

Media contact
Publicity Department of Jiande Municipal Committee
Email: heyn@8531.cn
Tel: +86 15857143688
Website: http://www.8531.cn

SOURCE: Publicity Department of Jiande Municipal Committee

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Seoul, Korea, Dec 2, 2022 – (ACN Newswire) – GobizKOREA announced the release of ‘Gobiz Town’, a Virtual Exhibition Platform to present domestic small and medium enterprise products to overseas buyers.

Gobiz Town is designed to provide a convenient experience to all without the restriction of time and space. It implies the ‘Go-Biz community’ with the exchange of domestic export companies and overseas buyers. With just a simple operation, users can look around the space as if users are strolling along the park. Various virtual halls are prepared for users to visit, such as:

• Institution Introduction Hall
• Export Products Exhibition Hall
• Metaverse Conference Hall, and Event Hall.

Overseas buyers can explore the online exhibition full of items like cosmetics and food as if they are at the actual exhibition without any inconvenience of screen transition and loading time. Single click can take buyers to the booth they want by using functions like search companies, maps, and aerial views.

Furthermore, once overseas buyers click on the exhibited product in the company booth, they can check various product images, product details, and price. English brochure and video manual are also arranged which enable buyers to send inquiries, request consultations, and purchase a sample product.

Gobiz Town can also support 2 types of metaverse conference halls. One is for online consultation between seller and buyer. And the other is for small-scale webinars, which is perfect for the corporate PR & investment attractions. Along with programs like “Follow-up management with trade experts”, “Online export training”, and “Mentoring”, Gobiz will provide users totally new experience in “Trade”.

The GobizKOREA project manager stated, ” Based on the user feedback, we will continue to make efforts to share better digital-based exhibition/trade service.” She added, “Starting this online exhibition project, with the infinite potential of Gobiz Town, we will plan, expand, and present various online exhibition contents in cooperation with the local government & institutions moving forward.”

Gobiz Town is not only limited to an online virtual space, but also it becomes the opportunity to expand channel from Online to Offline (O2O) for actual exhibitions, supporting for effectiveness in online exports.

Media Contact
Tahee Kim, GobizKOREA
E-mail: Tahee@Gobizkorea.com
Website: https://www.Gobizkorea.com/
Phone: +82-70-4771-5882

SOURCE: GobizKOREA

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Lisbon, Portugal, Dec 2, 2022 – (ACN Newswire) – Web3 Antivirus is launching on December 1, 2022, with a mission to become a reliable security guard for the Web3 community.

Fraud, scams, and phishing attacks are on the rise as scammers continually search for novel methods to unlawfully extract value from users. The more Web3 gains traction, the greater the need for efficient solutions to help users protect their assets. And this is exactly what Web3 Antivirus promises.

Web3 Antivirus (W3A) is a free open-source Chrome extension designed to help safely operate and collaborate in web3.

Powered by proprietary security audit frameworks, the tool guards users against signing dangerous transactions and dealing with suspicious assets. It shows an overview of potential red flags and technical risks associated with a transaction helping users make informed decisions about whether or not to proceed with it. What’s more, W3A simulates the transaction and displays what happens if it’s approved.

Web3 Antivirus does not ask for access to wallets, assets, or seed phrases, thus being a trustworthy security guard.

The extension also helps users steer clear of phishing websites: It checks domain names against its comprehensive database of blocklists and allowlists using AI similarity validation, identifies suspicious logic, and warns users if the website is dangerous.

W3A currently works with Ethereum and supports Metamask, Coinbase Wallet, and BitKeep Wallet, with other wallets to be added shortly.

According to Alex Dulub, the founder of Web3 Antivirus, “The key goal of the solution is to help the web3 community save billions of dollars by making the ecosystem a safer place to cooperate and work in, which will benefit all stakeholders in the long run.”

Social Links
Twitter: https://twitter.com/web3_antivirus
Medium: https://medium.com/@w3a
Linkedin: https://www.linkedin.com/company/web3-antivirus/

Media Contact
Contact: Xenia, Community manager, Web3 Antivirus
Email: support@w3a.tech
Website: https://web3antivirus.io

SOURCE: Web3 Antivirus

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com